Alexandria Real Estate Equities | ARE - Beneficio Operativo

Precio De Mercado
40.51
Cambio Diario
-0.54 -1.32%
Mensual
-12.73%
Anual
-44.82%
Q2 Expectativa
46.39




Beneficio Operativo Cambio Fecha
Alexandria Real Estate Equities USD 146.25M 2.79M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
American Homes 4 Rent USD 118.79M 2.47M 2025-12
Amgen USD 3.96B 464M 2025-12
AvalonBay Communities USD 230.74M 9.57M 2025-12
Boston Properties USD 254.59M 150.36M 2025-12
Brandywine Realty USD 21.41M 3.75M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Camden Property USD 245.86M 163.44M 2025-12
COPT Defense Properties USD 58.29M 16K 2026-03
Cousins Properties USD 56.13M 3.17M 2025-12
Digital Realty USD 285.45M 131.81M 2026-03
Douglas Emmett USD 44.76M 2.67M 2025-12
EastGroup Properties USD 76.4M 430K 2026-03
Eli Lilly USD 9.78B 792M 2026-03
EPR Properties USD 99.75M 4.61M 2025-09
Equity Lifestyle Properties USD 131.04M 4.47M 2025-12
Equity Residential USD 222.92M 3.62M 2025-12
Essex Property USD 152.14M 4.03M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Healthpeak Properties Inc USD 146.61M 14.83M 2025-12
Highwoods Properties USD 53.09M 473K 2025-12
Hudson Pacific Properties USD 47.52M 175.5M 2025-12
Illumina USD 256M 6M 2025-12
Kilroy Realty USD 63.27M 17.47M 2025-12
LTC Properties USD 34.67M 43.49M 2025-12
Medical Properties USD 169.11M 45.31M 2025-12
Mid-America Apartment Communities USD 186.28M 28.59M 2026-03
National Health Investors USD 50.36M 6.28M 2025-12
Omega Healthcare Investors USD 201.71M 4.4M 2025-12
ProLogis USD 827.03M 25.32M 2026-03
Quest Diagnostics USD 399M 13M 2026-03
Realty Income USD 690.29M 13.38M 2025-12
Rexford Industrial Realty USD 100.46M 7.66M 2026-03
SL Green Realty USD 24.42M 2.97M 2026-03
STAG Industrial USD 83.58M 3.33M 2025-12
Terreno Realty USD 48.06M 4.11M 2025-09
UDR USD 67.87M 21.75M 2026-03
Ventas USD 208.36M 26.53M 2026-03
Veris Residential USD 12.55M 2.61M 2026-03
Vornado Realty USD 64.06M 15.2M 2025-12
W. P. Carey USD 240.6M 21.03M 2026-03
Welltower USD 67.22B 68.24B 2026-03